<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39370044</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-4893</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>Clinical medicine (London, England)</Title><ISOAbbreviation>Clin Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>Effects of sulphur thermal water inhalations in long-COVID syndrome: Spa-centred, double-blinded, randomised case-control pilot study.</ArticleTitle><Pagination><StartPage>100251</StartPage><MedlinePgn>100251</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100251</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinme.2024.100251</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1470-2118(24)05436-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The long-COVID syndrome is characterised by a plethora of symptoms. Given its social and economic impact, many studies have stressed the urgency of proposing innovative strategies other than hospital settings. In this double-blinded, randomised, case-control trial, we investigate the effects of sulphur thermal water inhalations, rich in H<sub>2</sub>S, compared to distilled water inhalations on symptoms, inflammatory markers and nasal microbiome in long-COVID patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">About 30 outpatients aged 18-75 with positive diagnosis for long-COVID were randomised in two groups undergoing 12 consecutive days of inhalations. The active group (STW) received sulphur thermal water inhalations whereas the placebo group received inhalations of sterile distilled non-pyrogenic water (SDW). Each participant was tested prior treatment at day 1 (T0), after the inhalations at day 14 (T1) and at 3 months follow-up (T2). At each time point, blood tests, nasal swabs for microbiome sampling, pulmonary functionality tests (PFTs) and pro-inflammatory marker measure were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The scores obtained in the administered tests (6MWT, Borg score and SGRQ) at T0 showed a significant variation in the STW group, at T1 and T2. Serum cytokine levels and other inflammatory biomarkers reported a statistically significant decrease. Some specific parameters of PFTs showed ameliorations in the STW group only. Changes in the STW nasopharyngeal microbiota composition were noticed, especially from T0 to T2.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Inhalations of sulphur thermal water exerted objective and subjective improvements on participants affected by long-COVID. Significant reduction of inflammatory markers, dyspnoea scores and quantitative and qualitative changes in the nasopharyngeal microbiome were also assessed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crucianelli</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Thermal Medicine, Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariano</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valeriani</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Epidemiology and Biotechnologies, Department of Movement Human and Health Sciences, University of Rome Foro Italico, Piazza Lauro de Bosis 6, Rome 00135, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cocomello</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Thermal Medicine, Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianfranceschi</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Epidemiology and Biotechnologies, Department of Movement Human and Health Sciences, University of Rome Foro Italico, Piazza Lauro de Bosis 6, Rome 00135, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baseggio Conrado</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moretti</LastName><ForeName>Ferdinando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Thermal Medicine, Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotto d'Abusco</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mennuni</LastName><ForeName>Gioacchino</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Thermal Medicine, Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraioli</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Thermal Medicine, Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Ben</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano Spica</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Epidemiology and Biotechnologies, Department of Movement Human and Health Sciences, University of Rome Foro Italico, Piazza Lauro de Bosis 6, Rome 00135, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Thermal Medicine, Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy; Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy. Electronic address: mario.fontana@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Med (Lond)</MedlineTA><NlmUniqueID>101092853</NlmUniqueID><ISSNLinking>1470-2118</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hydrogen sulphide</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Nasal microbiome</Keyword><Keyword MajorTopicYN="N">Quality improvement</Keyword><Keyword MajorTopicYN="N">Sulphur thermal water</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39370044</ArticleId><ArticleId IdType="doi">10.1016/j.clinme.2024.100251</ArticleId><ArticleId IdType="pii">S1470-2118(24)05436-8</ArticleId><ArticleId IdType="pmc">PMC11570715</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Author Correction: Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(6):408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10408714</ArticleId><ArticleId IdType="pubmed">37069455</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerne K, Filion KB, Grad R, Ernst P, Gershon AS, Eisenberg MJ. Epidemiological and clinical perspectives of long COVID syndrome. Am J Med Open. 2023;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9846887</ArticleId><ArticleId IdType="pubmed">36685609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, Matched Cohort Study. Open Forum Infect Dis. 2022;9(9):ofac464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson MM, Qasmieh SA, Kulkarni SG, et al. The epidemiology of long coronavirus disease in US adults. Clin Infect Dis. 2023;76(9):1636&#x2013;1645.</Citation><ArticleIdList><ArticleId IdType="pubmed">36542514</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;eg TB, Ladhani S, Prasad V. How methodological pitfalls have created widespread misunderstanding about long COVID. BMJ Evid Based Med. 2024;29(3):142&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11137465</ArticleId><ArticleId IdType="pubmed">37748921</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClin Med. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, et al. Estimated global proportion of individuals with persistent fatigue, cognitive and respiratory symptoms cluster following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair PW, Brown DM, Jang M, et al. The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. Open Forum Infect Dis. 2021;8(2):ofab007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881750</ArticleId><ArticleId IdType="pubmed">33614816</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, B&#xe4;ck M, Bernardi M, et al. Cardiovascular disease as part of Long COVID: a systematic review. Eur J Prev Cardiol. 2024:zwae070.</Citation><ArticleIdList><ArticleId IdType="pubmed">38381595</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406&#x2013;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, et al. From online data collection to identification of disease mechanisms: the IL-1&#xdf;, IL-6 and TNF-&#x3b1; cytokine triad is associated with post-acute sequelae of COVID-19 in a Digital Research Cohort. SSRN Electron J. 2021;3(6):100663.</Citation></Reference><Reference><Citation>Murphy MC, Little BP. Chronic pulmonary manifestations of COVID-19 infection: imaging evaluation. Radiology. 2023;307(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888022</ArticleId><ArticleId IdType="pubmed">36692398</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, et al. Corrigendum to &#x201c;The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClin Med. 2023;59</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10115131</ArticleId><ArticleId IdType="pubmed">37096187</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post&#x2013;COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18(5):799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro Carvalho CR, Lamas CA, Chate RC, et al. Long-term respiratory follow-up of ICU hospitalized COVID-19 patients: prospective cohort study. PLoS One. 2023;18(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9858876</ArticleId><ArticleId IdType="pubmed">36662879</ArticleId></ArticleIdList></Reference><Reference><Citation>Masiero S, Maccarone MC, Magro G. Balneotherapy and human immune function in the era of COVID-19. Int J Biometeorol. 2020;64(8):1433&#x2013;1434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7160818</ArticleId><ArticleId IdType="pubmed">32300868</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccarone MC, Masiero S. Spa therapy interventions for post respiratory rehabilitation in COVID-19 subjects: does the review of recent evidence suggest a role? Environm Sci Pollut Res. 2021;28(33):46063&#x2013;46066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286038</ArticleId><ArticleId IdType="pubmed">34273080</ArticleId></ArticleIdList></Reference><Reference><Citation>Mooventhan A, Nivethitha L. Scientific evidence-based effects of hydrotherapy on various systems of the body. N Am J Med Sci. 2014;6(5):199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049052</ArticleId><ArticleId IdType="pubmed">24926444</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfaldoni S, Tchernev G, Wollina U, Roccia MG, Fioranelli M, Gianfaldoni R, et al. History of the baths and thermal medicine. Open Access Maced J Med Sci. 2017;5(4):566&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5535686</ArticleId><ArticleId IdType="pubmed">28785361</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini M, Fanin D, Nowicki Y, Guarnieri G, Bordin A, Faggian D, et al. Effect of inhalation of thermal water on airway inflammation in chronic obstructive pulmonary disease. Respir Med. 2005;99(6):748&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">15878492</ArticleId></ArticleIdList></Reference><Reference><Citation>Geological Factors. In 2004. bl 38&#x2013;235. Available at: https://linkinghub.elsevier.com/retrieve/pii/S157191970480003X.</Citation></Reference><Reference><Citation>Zajac D. Inhalations with thermal waters in respiratory diseases. J Ethnopharmacol. 2021;281</Citation><ArticleIdList><ArticleId IdType="pubmed">34371115</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailly M, Evrard B, Coudeyre E, et al. Health management of patients with COVID-19: is there a room for hydrotherapeutic approaches? Int J Biometeorol. 2022;66(5):1031&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789204</ArticleId><ArticleId IdType="pubmed">35079866</ArticleId></ArticleIdList></Reference><Reference><Citation>Iciek M, Bilska-Wilkosz A, Kozdrowicki M, G&#xf3;rny M. Reactive sulfur compounds in the fight against COVID-19. Antioxidants. 2022;11(6):1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9220020</ArticleId><ArticleId IdType="pubmed">35739949</ArticleId></ArticleIdList></Reference><Reference><Citation>Magli E, Perissutti E, Santagada V, et al. H2S donors and their use in medicinal chemistry. Biomolecules. 2021;11(12):1899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8699746</ArticleId><ArticleId IdType="pubmed">34944543</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuozzo E, Giorgi A, Canterini S, et al. A proteomic approach to study the effect of thiotaurine on human neutrophil activation. Adv Exp Med Biol. 2017:563&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">28849482</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuozzo E, Pecci L, Conrado AB, Fontana M. Thiotaurine prevents apoptosis of human neutrophils: a putative role in inflammation. Adv Exp Med Biol. 2013:227&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">23392938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazhanov N, Escaffre O, Freiberg AN, Garofalo RP, Casola A. Broad-range antiviral activity of hydrogen sulfide against highly pathogenic RNA viruses. Sci Rep. 2017;7(1):41029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5247713</ArticleId><ArticleId IdType="pubmed">28106111</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi G, Masselli E, Gobbi G, Mirandola P, Taborda-Barata L, Ampollini L, et al. Hydrogen sulfide inhibits TMPRSS2 in human airway epithelial cells: implications for SARS-CoV-2 infection. Biomedicines. 2021;9(9):1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8469712</ArticleId><ArticleId IdType="pubmed">34572459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Wang X, Chen S, et al. Endogenous hydrogen sulfide sulfhydrates IKK&#x3b2; at cysteine 179 to control pulmonary artery endothelial cell inflammation. Clin Sci. 2019;133(20):2045&#x2013;2059.</Citation><ArticleIdList><ArticleId IdType="pubmed">31654061</ArticleId></ArticleIdList></Reference><Reference><Citation>Candel S, Tyrkalska SD, &#xc1;lvarez-Santacruz C, Mulero V. The nasopharyngeal microbiome in COVID-19. Emerg Microbes Infect. 2023;12(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9869994</ArticleId><ArticleId IdType="pubmed">36606725</ArticleId></ArticleIdList></Reference><Reference><Citation>Merenstein C, Bushman FD, Collman RG. Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance. Microbiome. 2022;10(1):165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9532226</ArticleId><ArticleId IdType="pubmed">36195943</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Wang L, Zheng X, Wen Y, Zhang Z, Fan L, et al. Moraxella occupied the largest proportion in the nasal microbiome in healthy children, which potential protect them from COVID-19. Microb Pathog. 2022;170</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9299982</ArticleId><ArticleId IdType="pubmed">35870694</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A, Costantini C, Renga G, Pariano M, Ricci G, Romani L. The microbiota/host immune system interaction in the nose to protect from COVID-19. Life. 2020;10(12):345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7763594</ArticleId><ArticleId IdType="pubmed">33322584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JG, Zhang A, Rauseo AM, et al. The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma. Allergy. 2022;77(12):3676&#x2013;3679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350136</ArticleId><ArticleId IdType="pubmed">35837881</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer S, Herzmann C, Gaede KI, Kovacevic D, Krauss-Etschmann S, Schloter M. Different responses of the oral, nasal and lung microbiomes to cigarette smoke. Thorax. 2022;77(2):191&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8762037</ArticleId><ArticleId IdType="pubmed">34389656</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-Santacruz C, Tyrkalska SD, Candel S. The microbiota in long-COVID. Int J Mol Sci. 2024;25(2):1330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10816132</ArticleId><ArticleId IdType="pubmed">38279329</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.random.org/sequences/, 2024</Citation></Reference><Reference><Citation>https://www.termediroma.org/pdf/analisi-chimico-fisico-2018.pdf, 2018.</Citation></Reference><Reference><Citation>https://www.birmingham.ac.uk/research/applied-health/research/symptom-burden-questionnaire/index.aspx, 2024.</Citation></Reference><Reference><Citation>R&#xf6;thlin P, Ackeret N, Birrer D, Peter C, Horvath S. Mental (ill-)health of Swiss elite athletes. Curr Iss Sport Sci. 2023;8(2):073.</Citation></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166(10):1092.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.sgul.ac.uk/research/research-operations/research-administration/st-georges-respiratory-questionnaire/docs/sgrq-c-manual-april-2012.pdf, 2024.</Citation></Reference><Reference><Citation>https://sgrq.github.io/, 2024.</Citation></Reference><Reference><Citation>Pires IM, Denysyuk HV, Villasana MV, et al. Development technologies for the monitoring of six-minute walk test: a systematic review. Sensors. 2022;22(2):581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782011</ArticleId><ArticleId IdType="pubmed">35062542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam GY, Befus AD, Damant RW, et al. Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype? Respir Res. 2021;22(1):222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343348</ArticleId><ArticleId IdType="pubmed">34362372</ArticleId></ArticleIdList></Reference><Reference><Citation>https://mocacognition.com/paper/#, 2024.</Citation></Reference><Reference><Citation>Valeriani F, Protano C, Gianfranceschi G, et al. Infection control in healthcare settings: perspectives for mfDNA analysis in monitoring sanitation procedures. BMC Infect Dis. 2016;16(1):394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4977761</ArticleId><ArticleId IdType="pubmed">27507586</ArticleId></ArticleIdList></Reference><Reference><Citation>Valeriani F, Agodi A, Casini B, et al. Potential testing of reprocessing procedures by real-time polymerase chain reaction: a multicenter study of colonoscopy devices. Am J Infect Control. 2018;46(2):159&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">28958445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kittelmann S, Seedorf H, Walters WA, et al. Simultaneous amplicon sequencing to explore co-occurrence patterns of bacterial, archaeal and eukaryotic microorganisms in rumen microbial communities. PLoS One. 2013;8(2):e47879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3568148</ArticleId><ArticleId IdType="pubmed">23408926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Y. Btrim: a fast, lightweight adapter and quality trimming program for next-generation sequencing technologies. Genomics. 2011;98(2):152&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651976</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Garrity GM, Tiedje JM, Cole JR. Na&#xef;ve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261&#x2013;5267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950982</ArticleId><ArticleId IdType="pubmed">17586664</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronavirusCOVID19infectionintheuk/1april2021, 2021.</Citation></Reference><Reference><Citation>Viechtbauer W, Smits L, Kotz D, et al. A simple formula for the calculation of sample size in pilot studies. J Clin Epidemiol. 2015;68(11):1375&#x2013;1379.</Citation><ArticleIdList><ArticleId IdType="pubmed">26146089</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.crutzen.net/n.htm, 2024.</Citation></Reference><Reference><Citation>Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287. &#x2013;91.</Citation></Reference><Reference><Citation>Antonelli M, Donelli D. Respiratory rehabilitation for post-COVID19 patients in spa centers: first steps from theory to practice. Int J Biometeorol. 2020;64(10):1811&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7380660</ArticleId><ArticleId IdType="pubmed">32710297</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.rivaluta.it/calcola_variazione_percentuale.asp, 2024.</Citation></Reference><Reference><Citation>https://www.primer-e.com/, 2024.</Citation></Reference><Reference><Citation>Colwell RK, Chao A, Gotelli NJ, et al. Models and estimators linking individual-based and sample-based rarefaction, extrapolation and comparison of assemblages. J Plant Ecol. 2012;5(1):3&#x2013;21.</Citation></Reference><Reference><Citation>Arndt D, Xia J, Liu Y, et al. METAGENassist: a comprehensive web server for comparative metagenomics. Nucleic Acids Res. 2012;40(W1):W88&#x2013;W95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3394294</ArticleId><ArticleId IdType="pubmed">22645318</ArticleId></ArticleIdList></Reference><Reference><Citation>Masiero S, Maccarone MC, Agostini F. Health resort medicine can be a suitable setting to recover disabilities in patients tested negative for COVID-19 discharged from hospital? A challenge for the future. Int J Biometeorol. 2020;64(10):1807&#x2013;1809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272594</ArticleId><ArticleId IdType="pubmed">32504142</ArticleId></ArticleIdList></Reference><Reference><Citation>Clementi M, Signorelli C, Spica VR, Vitali M, Conti M, Vitale M. Protocols and self-checking plans for the safety of post-covid-19 balneotherapy. Acta Biomedica. 2020;91:40&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023090</ArticleId><ArticleId IdType="pubmed">32701916</ArticleId></ArticleIdList></Reference><Reference><Citation>la Marca G, Barp J, Frenos S, et al. Thermal inactivation of SARS COVID-2 virus: are steam inhalations a potential treatment? Life Sci. 2021;265</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680040</ArticleId><ArticleId IdType="pubmed">33232690</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicconetti F, Sestili P, Madiai V, et al. Extracellular pH, osmolarity, temperature and humidity could discourage SARS-CoV-2 cell docking and propagation via intercellular signaling pathways. PeerJ. 2021;9:e12227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515994</ArticleId><ArticleId IdType="pubmed">34721966</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury MNR, Alif YA, Alam S, et al. Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approaches. Heliyon. 2022;8(1):e08816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8783838</ArticleId><ArticleId IdType="pubmed">35097233</ArticleId></ArticleIdList></Reference><Reference><Citation>Renieris G, Katrini K, Damoulari C, et al. Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 Coronavirus. Shock. 2020;54(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363385</ArticleId><ArticleId IdType="pubmed">32433216</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominic P, Ahmad J, Bhandari R, et al. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19. Redox Biol. 2021;43</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8106525</ArticleId><ArticleId IdType="pubmed">34020311</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, et al. Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J Clin Med. 2022;11(6):1541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Frara S, Nannipieri F, et al. Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors. J Clin Endocrinol Metab. 2023;108(10):e1106&#x2013;e1116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="pubmed">37051747</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumbalova Z, Kucharska J, Palacka P, et al. Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19. Bratislava Med J. 2021;123(01):9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">34967652</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmetz A, Bahlmann S, Bergelt C, et al. The Greifswald post COVID Rehabilitation Study and Research (PoCoRe)&#x2013;study design, characteristics and evaluation tools. J Clin Med. 2023;12(2):624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9861069</ArticleId><ArticleId IdType="pubmed">36675551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowska M, Rzepka-Cholasi&#x144;ska A, Pietrzykowski &#x141;, et al. Effects of multidisciplinary rehabilitation program in patients with long COVID-19: post-COVID-19 rehabilitation (PCR SIRIO 8) study. J Clin Med. 2023;12(2):420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9864838</ArticleId><ArticleId IdType="pubmed">36675349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzoletti L, Zanolin ME, Dorelli G, et al. Six-minute walk distance in healthy subjects: reference standards from a general population sample. Respir Res. 2022;23(1):83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8985335</ArticleId><ArticleId IdType="pubmed">35382813</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachid C, Zouine Y, Benzalim M, Alj S, Amro L. Persistant post-covid 19 intertitial lung disease. SCIREA J Clin Med. 2023;8(1):68&#x2013;77.</Citation></Reference><Reference><Citation>Bongiovanni M, Barilaro G, Bini F. Twelve-month clinical, functional, and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia. J Med Virol. 2023;95(2)</Citation><ArticleIdList><ArticleId IdType="pubmed">36695513</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R, Latorre A, Gonz&#xe1;lez-Jim&#xe9;nez P, et al. Reduced diffusion capacity in COVID-19 survivors. Ann Am Thorac Soc. 2021;18:1253&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328367</ArticleId><ArticleId IdType="pubmed">33472019</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27(4):328&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuschillo S, Ambrosino P, Motta A, Maniscalco M. Covid-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings. Biomark Med. 2021;15(8):537&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8120998</ArticleId><ArticleId IdType="pubmed">33988464</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Graham BL, Cooper BG, et al. Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50(3)</Citation><ArticleIdList><ArticleId IdType="pubmed">28893868</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A, Rosso A, Cecchini P, et al. One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome. Infection. 2022;50(2):513&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8777423</ArticleId><ArticleId IdType="pubmed">35061232</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, et al. Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. 2022;101(6):593&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of long COVID symptoms. Front Med (Lausanne) 2023;10:1011936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti M, De Berardis B, Bigioni I, Mariano A, Superti F, Scotto d'Abusco A. In vitro antiviral and anti-inflammatory activities of n-acetylglucosamine: development of an alternative and safe approach to fight viral respiratory infections. Int J Mol Sci. 2023;24(6):5129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10049122</ArticleId><ArticleId IdType="pubmed">36982205</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J Biol Sci. 2022;18(12):4768&#x2013;4780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza O, Leggiero E, De Benedictis G, et al. S100B induces the release of pro-inflammatory cytokines in alveolar type I-like cells. Int J Immunopathol Pharmacol. 2013;26(2):383&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">23755753</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceti A, Margarucci LM, Scaramucci E, et al. Serum S100B protein as a marker of severity in Covid-19 patients. Sci Rep. 2020;10(1):18665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7596559</ArticleId><ArticleId IdType="pubmed">33122776</ArticleId></ArticleIdList></Reference><Reference><Citation>Mete E, Sabirli R, Goren T, Turkcuer I, Kurt &#xd6;, Koseler A. Association between s100b levels and covid-19 pneumonia: a case control study. In Vivo (Brooklyn) 2021;35(5):2923&#x2013;2928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8408717</ArticleId><ArticleId IdType="pubmed">34410988</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel SK, Juno JA, Lee WS, et al. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences. Eur Respir J. 2021;57(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7830336</ArticleId><ArticleId IdType="pubmed">33479113</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Fejes Z, S&#xfc;t&#x151; R, et al. Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients. Int J Infect Dis. 2022;115:8&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613979</ArticleId><ArticleId IdType="pubmed">34838959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell PD, Buckley C, Subramaniam A, Crowther S, Donnelly SC. Elevated serum ACE levels in patients with post-acute COVID-19 syndrome. QJM. 2022;115(10):651&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384078</ArticleId><ArticleId IdType="pubmed">35588264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu SC. Glutathione synthesis. Biochimica et Biophysica Acta (BBA) - General Subjects. 2013;1830(5):3143&#x2013;3153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549305</ArticleId><ArticleId IdType="pubmed">22995213</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K, Wu ZX, Chen XY, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubourg G, Edouard S, Raoult D. Relationship between nasopharyngeal microbiota and patient's susceptibility to viral infection. Expert Rev Anti Infect Ther. 2019;17(6):437&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pubmed">31106653</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016&#x2013;1035.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez Baumgartner M, Li C, Kuntz TM, et al. Differences of the nasal microbiome and mycobiome by clinical characteristics of COPD patients. Chronic Obstruct Pulmon Dis: J COPD Foundation. 2022;9(3):309&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9448003</ArticleId><ArticleId IdType="pubmed">35487694</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan VR, Holt J, Nelson LF, Ir D, Robertson CE, Frank DN. Determinants of the nasal microbiome: pilot study of effects of intranasal medication use. Allergy Rhinol. 2018;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6088474</ArticleId><ArticleId IdType="pubmed">30128169</ArticleId></ArticleIdList></Reference><Reference><Citation>Llor&#xe9;ns-Rico V, Gregory AC, Van Weyenbergh J, et al. Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host. Nat Commun. 2021;12(1):6243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556379</ArticleId><ArticleId IdType="pubmed">34716338</ArticleId></ArticleIdList></Reference><Reference><Citation>Konovalovas A, Armalyt&#x117; J, Klimkait&#x117; L, et al. Human nasal microbiota shifts in healthy and chronic respiratory disease conditions. BMC Microbiol. 2024;24(1):150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11055347</ArticleId><ArticleId IdType="pubmed">38678223</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamash DF, Mongodin EF, White JR, et al. The association between the developing nasal microbiota of hospitalized neonates and staphylococcus aureus colonization. Open Forum Infect Dis. 2019;6(4):ofz062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6441571</ArticleId><ArticleId IdType="pubmed">30949531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanmani P, Clua P, Vizoso-Pinto MG, et al. Respiratory commensal bacteria corynebacterium pseudodiphtheriticum improves resistance of infant mice to respiratory syncytial virus and streptococcus pneumoniae superinfection. Front Microbiol. 2017;8:1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5572367</ArticleId><ArticleId IdType="pubmed">28878760</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkov VA, Silachev DN, Zalevsky AO, Zorov DB, Plotnikov EY. Mitochondria as a source and a target for uremic toxins. Int J Mol Sci. 2019;20(12):3094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6627204</ArticleId><ArticleId IdType="pubmed">31242575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Yu L, Xu C, et al. Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function. PLoS One. 2018;13(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6133361</ArticleId><ArticleId IdType="pubmed">30204780</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>